Edwards Lifesciences Corp
EW- Exchange
- NYSE
- Industry
- Orthopedic, Prosthetic & Surgical Appliances & Supplies
- SEC CIK
- 0001099800
In the last 90 days, Edwards Lifesciences Corp insiders filed 0 open-market purchases and 9 sales; 1,348 institutions reported holding it in 13F filings for Q2 2026, worth $47.2B in total; no superinvestor holds it.
Key figures
- Market capClose on Nov 11, 2026
- $60.8B
- Insider buysOpen market, last 90 days
- 0
- Insider sellsLast 90 days, $10.9M in total
- 9
- 13F holdersQ2 2026, +63 vs. previous quarter
- 1,348
- 13F valueReported value at the end of Q2 2026
- $47.2B
- Superinvestors holdingAt the end of Q2 2026
- 0
Price chart
Financials
See financial statementsFrom SEC filings, in USD.
- Revenue, FY2025
- $6.07B
- +11.5% year over year
- Net income, FY2025
- $1.07B
- −74.3% year over year
- Free cash flow, FY2025
- $1.33B
- +360.5% year over year
- Revenue, Q3 FY2026
- $1.72B
- +10.5% year over year
Revenue flow, FY2025
Green is profit; orange is costs, expenses and taxes. Percentages are shares of revenue.
Short interest
See short dataFrom FINRA, settlement date Oct 30, 2026.
- Short interest
- 9.38M
- Shares sold short
- Change
- +48.8K
- +0.5% vs. previous
- Days to cover
- 2.80
- At average daily volume
Superinvestors holding EW, Q2 2026
Go to the superinvestors tabNo superinvestor reported holding EW at the end of Q2 2026.
Latest insider trades
See all insider tradesOpen-market purchases and sales by Edwards Lifesciences Corp insiders from Form 4, newest first.
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Nov 10, 2026 (view filing)4:52 PM ET | Nov 10 | Same day | Lippis Daniel J.CVP, TAVR | SSale | −619 | $104.25 | −$64.5K | −1.5%40.0K after | 10b5-1 |
| Nov 9, 2026 (view filing)4:29 PM ET | Nov 9 | Same day | Zovighian Bernard JCEO | SSale | −23.1K | $103.02 | −$2.38M | −18.9%98.8K after | 2 lots10b5-1 |
| Nov 9, 2026 (view filing)4:29 PM ET | Nov 9 | Same day | Bobo Donald E JrCVP,Strategy/Corp Development | SSale | −48.9K | $103.05 | −$5.04M | −68.2%22.8K after | 10b5-1 |
| Oct 8, 2026 (view filing)5:24 PM ET | Oct 8 | Same day | Lippis Daniel J.CVP, TAVR | SSale | −619 | $85.65 | −$53.0K | −1.5%40.0K after | 10b5-1 |
| Sep 11, 2026 (view filing)7:15 PM ET | Sep 11 | Same day | Lippis Daniel J.CVP, TAVR | SSale | −619 | $87.51 | −$54.2K | −1.5%40.0K after | 10b5-1 |
| Aug 31, 2026 (view filing)5:47 PM ET | Aug 31 | Same day | Dahl Andrew M.SVP, Corporate Controller | SSale | −544 | $91.06 | −$49.5K | −3.5%14.9K after | |
| Aug 28, 2026 (view filing)4:32 PM ET | Aug 28 | Same day | Bruls AnnetteCVP, EMEACLA | SSale | −2.64K | $89.98 | −$237.9K | −12.8%18.0K after | |
| Aug 26, 2026 (view filing)6:36 PM ET | Aug 26 | Same day | Chopra DaveenCVP, TMTT, Surgical & IHFM | SSale | −31.8K | $91.02 | −$2.89M | −41.8%44.3K after | 2 lots |
| Aug 26, 2026 (view filing)6:00 PM ET | Aug 26 | Same day | Markowitz WayneCVP, JAPAC | SSale | −1.24K | $91.47 | −$113.4K | −5.8%20.3K after | |
| Aug 11, 2026 (view filing)5:07 PM ET | Aug 11 | Same day | Lippis Daniel J.CVP, TAVR | SSale | −619 | $92.03 | −$57.0K | −1.5%40.0K after | 10b5-1 |
Top 10 13F holders, Q2 2026
See all 1,348 holdersThe largest institutional positions in Edwards Lifesciences Corp at the end of Q2 2026; share changes are against Q1 2026.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| BlackRock, Inc. | 58,789,433 | $5.32B | 0.08% | +6,198,500+11.8% | Added |
| Vanguard Capital Management LLC | 37,615,952 | $3.40B | 0.07% | −111,840−0.3% | Reduced |
| Vanguard Portfolio Management LLC | 26,411,402 | $2.39B | 0.11% | +4,3840.0% | Added |
| State Street Corp | 26,321,940 | $2.38B | 0.07% | +25,541+0.1% | Added |
| JPMorgan Chase & Co | 22,783,175 | $2.08B | 0.12% | +1,038,463+4.8% | Added |
| Wellington Management Group LLP | 16,827,967 | $1.52B | 0.26% | −5,183,134−23.5% | Reduced |
| Geode Capital Management, LLC | 15,437,251 | $1.39B | 0.07% | +2,303,474+17.5% | Added |
| Bank of New York Mellon Corp | 14,084,483 | $1.27B | 0.21% | −2,653,065−15.9% | Reduced |
| DZ BANK AG Deutsche Zentral Genossenschafts Bank, Frankfurt am Main | 13,002,965 | $1.18B | 0.92% | +191,063+1.5% | Added |
| Ninety One UK Ltd | 12,337,502 | $1.12B | 2.50% | −58,641−0.5% | Reduced |
Holders of 5% or more of EW
See all 2 holders and filingsHolders whose latest Schedule 13D or 13G filing reports 5% or more of Edwards Lifesciences Corp.
| Holder | Latest form | Stake | Change | First filed | Latest filing | Filing |
|---|---|---|---|---|---|---|
| Vanguard Capital Management LLC | 13G | 7.54%43.5M shares | New | Apr 29, 20261 filing | Apr 29, 2026 | SEC |
| BlackRock, Inc. | 13G/A | 7.50%44.3M shares | – | Oct 17, 20251 filing | Oct 17, 2025 | SEC |
Politician trades
All politician trades in EW13 members of Congress reported 28 trades in Edwards Lifesciences Corp since 2020. Newest filings:
| Filed | Politician | Type | Amount |
|---|---|---|---|
| Jul 21, 2026 |  Alan Armstrong Senate · OK | Buy | $1K-$15K |
| Dec 29, 2025 |  Josh Gottheimer House · NJ | Sell | $1K-$15K |
| Jun 22, 2025 |  Jefferson Shreve House · IN | Sell | $50K-$100K |
| May 12, 2025 |  Bruce Westerman House · AR | Sell | $1K-$15K |
| May 8, 2025 |  Robert P. Bresnahan, Jr. House · PA | Buy | $1K-$15K |
Senate · OK · Jul 21, 2026
Buy$1K-$15K
House · NJ · Dec 29, 2025
Sell$1K-$15K
House · IN · Jun 22, 2025
Sell$50K-$100K
House · AR · May 12, 2025
Sell$1K-$15K
House · PA · May 8, 2025
Buy$1K-$15K